阿尔茨海默病知识库:阿尔茨海默病研究知识图
Joseph D Romano1,2,3, Van Truong1,4,5, Rachit Kumar1,4,5,6
1Institute for Biomedical Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Journal of medical Internet research
|April 18, 2024
概括
一个新的阿尔茨海默病知识库 (AlzKB) 通过整合各种数据来帮助药物发现. 它确定了新的治疗点,并重新利用药物,为神经退行性疾病研究提供了宝贵的工具.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物信息学是一种生物信息学.
背景情况:
- 全球人口老龄化增加了对神经退行性疾病 (如阿尔茨海默氏症) 的易感性.
- 现有的数据资源缺乏AD病因和药物反应的全面关系.
- 迫切需要新的治疗方法和改进的药物发现/重新用途工具来治疗AD.
研究的目的:
- 开发阿尔茨海默氏症知识库 (AlzKB),以全面地代表阿尔茨海默氏症的知识.
- 为了捕捉AD病因学和候选治疗方法,以改善药物发现.
- 为AD研究提供公共,可访问的资源.
主要方法:
- 构建AlzKB作为一个大型的,异构的图形知识库.
- 整合了22个不同的外部数据源 (化学物质,基因,解剖学,疾病).
- 利用Web本体语言2用于语义一致性和本体推理.
主要成果:
- 在AlzKB中,有118,902个实体和1,309,527个关系.
- 应用图形数据科学和机器学习,提出新的治疗目标.
- 成功地重新使用现有药物,并确定了AD的新疗法协会.
结论:
- AlzKB是一个新的,公开可用的知识资源,用于AD药物发现.
- 能够发现复杂的翻译关联.
- 从公共生物医学知识中提出新的治疗假设的价值.
相关概念视频
Alzheimer's Disease: Overview
468
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
468
Alzheimer's Disease: Treatment
183
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
183
Dementia
113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
113
Amnesia
123
Amnesia is a condition marked by long-term memory loss, which impairs the ability to recall past events or create new memories.
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
123
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541


